These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Eruption during treatment with oxprenolol. Levene GM; Gange RW Br Med J; 1978 Mar; 1(6115):784. PubMed ID: 147124 [No Abstract] [Full Text] [Related]
7. A distinctive eruption in patients receiving oxprenolol. Gange RW; Levene GM Clin Exp Dermatol; 1979 Mar; 4(1):87-97. PubMed ID: 156099 [No Abstract] [Full Text] [Related]
8. Ocular reaction to oxprenolol. A case report. Lewis BS; Setzen M; Kokoris N S Afr Med J; 1976 Mar; 50(12):482-3. PubMed ID: 131980 [TBL] [Abstract][Full Text] [Related]
9. Hyperpigmentation associated with oxprenolol administration. Harrower AD; Strong JA Br Med J; 1977 Jul; 2(6082):296. PubMed ID: 871864 [No Abstract] [Full Text] [Related]
11. Thrombocytopenia due to oxprenolol. Hare DL; Hicks BH Med J Aust; 1979 Sep; 2(5):259. PubMed ID: 514164 [No Abstract] [Full Text] [Related]
12. Letter: Adverse reactions to beta-adrenergic blockade. Mithal A Br Med J; 1974 Jun; 2(5917):503. PubMed ID: 4151839 [No Abstract] [Full Text] [Related]
13. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension. O'Brien KP; Stephens EJ N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924 [TBL] [Abstract][Full Text] [Related]
14. Thrombocytopenia secondary to oxprenolol, a beta-blocking agent. Patrassi GM; Casonato A; Fabris F; Girolami A Acta Haematol; 1982; 68(1):75-6. PubMed ID: 6812363 [No Abstract] [Full Text] [Related]
15. Propranolol, oxprenolol, and sclerosing peritonitis. Marigold JH; Pounder RE; Pemberton J; Thompson RP Br Med J (Clin Res Ed); 1982 Mar; 284(6319):870. PubMed ID: 6802333 [No Abstract] [Full Text] [Related]
16. Letter: Ocular reactions to beta-blockers. Br Med J; 1975 Jun; 2(5970):557. PubMed ID: 238715 [No Abstract] [Full Text] [Related]